Biblioteca Humberto Rosselli Quijano
[artículo]
| Título : |
Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics |
| Tipo de documento: |
texto impreso |
| Autores: |
Steven G. Potkin, Autor ; Kirsten Fleming, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 479-483 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Etiquetas: |
Antipsicóticos, Clozapina, Cognición, Trastornos cognitivos, Haloperidol, Pruebas neuropsicológicas, Esquizofrenia. |
| Resumen: |
Neurocognition and clinical symptomatology were evaluated in 27 patients with schizophrenia during a double-blind, placebo-controlled, crossover study involving clozapine, an atypical antipsychotic agent, and haloperidol, a conventional neuroleptic. Patients were assessed 5 to 6 weeks after initiation of each phase. |
| Link: |
./index.php?lvl=notice_display&id=31109 |
in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 479-483
[artículo] Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics [texto impreso] / Steven G. Potkin, Autor ; Kirsten Fleming, Autor . - 2023 . - pp. 479-483. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2001 - Vol. 21 - No. 5 (Octubre) . - pp. 479-483
| Etiquetas: |
Antipsicóticos, Clozapina, Cognición, Trastornos cognitivos, Haloperidol, Pruebas neuropsicológicas, Esquizofrenia. |
| Resumen: |
Neurocognition and clinical symptomatology were evaluated in 27 patients with schizophrenia during a double-blind, placebo-controlled, crossover study involving clozapine, an atypical antipsychotic agent, and haloperidol, a conventional neuroleptic. Patients were assessed 5 to 6 weeks after initiation of each phase. |
| Link: |
./index.php?lvl=notice_display&id=31109 |
|
